Gland Pharma shares: Promoter Fosun Pharma likely to divest 5% equity worth Rs 2,279 crore via block deal

As reported by Stocks-Markets-Economic Times

Fosun Pharma plans to divest 5% equity in Gland Pharma through a Rs 2,279.5 crore block deal at Rs 2,763 per share. Gland Pharma reported a 47% rise in Q1FY27 profit and operates globally, with strong R&D and growth.

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on Stocks-Markets-Economic Times ↗

Market Samachar is a news aggregator. This article was originally published by Stocks-Markets-Economic Times. Tap the button above to read the full story on their site.

INDIAN Kanohar Electricals, Arcil, Glass Wall Systems fix IPO price bands Share Market Today
INDIAN National Stock Exchange to revise pre-open auction framework from Sept 7 Share Market Today
INDIAN CAS mechanism effect: Sebi to review derivatives trades pricing Share Market Today
INDIAN XTGlobal secures cloud engineering and services contract from U.S. State Govt. Share Market Today
INDIAN Kalyani Strategic Systems signs strategic alliance agreement with Thales for 70-mm rocket systems Share Market Today
INDIAN Kalyani Strategic Systems signs MoU with FN Herstal Share Market Today
INDIAN Ramco Systems signs MoU with Safran Helicopter Engines Share Market Today
INDIAN CreditAccess Grameen successfully raises Rs 300 cr via NCDs Share Market Today

Gland Pharma shares: Promoter Fosun Pharma likely to divest 5% equity worth Rs 2,279 crore via block deal

More from Market Samachar